Showing results (231-240 of 1,137) with videos related to

Sort By:
Pageof 114
Dermatitis : Contact, Atopic, Occupational, Drug|August 12, 2025
Skin Testing for the Exploration of Immediate and Delayed Hypersensitivity to Fluoroquinolones: Insights From a Real-Life Cohort StudyJulie Boo, Damien Lannoy, Johana Bene, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 18, 2021
Patch Test Reactions Associated With Topical Medications: A Retrospective Analysis of the North American Contact Dermatitis Group Data (2001-2018)Erin M Warshaw, Rob L Shaver, Joel G DeKoven, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 5, 2020
T Helper 2 Inhibitors in Allergic Contact DermatitisCatherine M Ludwig, Jeffrey M Krase, Vivian Y Shi
Dermatitis : Contact, Atopic, Occupational, Drug|June 20, 2025
New and Emerging Pharmacotherapies for Pruritus: A Systematic Review and Network Meta-AnalysisHan Li, Anita Arthur, Mahtab Forouzandeh, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|December 12, 2025
The Dual Role of Staphylococcus epidermidis in Atopic Dermatitis: Pathobiont and ProtectorMahsa Khosrojerdi, Seyed Ahmad Hashemi, Ali Haghbin, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 10, 2025
What Does Long-Term Control in Atopic Dermatitis Look Like?Shanthi Narla, Zelma C Chiesa Fuxench, Katrina Abuabara, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 24, 2025
Higher Occurrence of Ocular Surface Disease Symptoms in Patients with Atopic Dermatitis: Data from 57,464 Subjects in the FOREVER CohortPernille May Hansen, Jens Rovelt, Josefine Freiberg, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|January 10, 2025
Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension TrialEric L Simpson, Lawrence F Eichenfield, Kim A Papp, et al.
Pageof 114